The effects of conjugated linoleic acid supplementation on glycemic control, adipokines, cytokines, malondialdehyde and liver function enzymes in patients at risk of cardiovascular disease: a GRADE-assessed systematic review and dose–response meta-analysis

[1]  Farideh Shiraseb,et al.  The effects of conjugated linoleic acid supplementation on inflammatory cytokines and adipokines in adults: A GRADE-assessed systematic review and dose–response meta-analysis , 2023, Frontiers in Immunology.

[2]  Farideh Shiraseb,et al.  The effects of conjugated linoleic acid supplementation on liver function enzymes and malondialdehyde in adults: A GRADE-assessed systematic review and dose-response meta-analysis. , 2022, Pharmacological research.

[3]  J. Heshmati,et al.  The effect of Conjugated Linoleic Acid intake on oxidative stress parameters and antioxidant enzymes: a systematic review and meta-analysis of randomized clinical trials. , 2022, Prostaglandins & other lipid mediators.

[4]  F. Farzadfar,et al.  The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran , 2022, Medical journal of the Islamic Republic of Iran.

[5]  Wanich Suksatan,et al.  The effect of conjugated linoleic acid supplementation on oxidative stress markers: A systematic review and meta-analysis of randomized controlled trials. , 2022, Clinical nutrition ESPEN.

[6]  S. Saha,et al.  Nutraceuticals in the Management of Cardiovascular Risk Factors: Where is the Evidence? , 2021, Cardiovascular & hematological disorders drug targets.

[7]  J. Walkowiak,et al.  Body Fat Changes and Liver Safety in Obese and Overweight Women Supplemented with Conjugated Linoleic Acid: A 12-Week Randomised, Double-Blind, Placebo-Controlled Trial , 2020, Nutrients.

[8]  A. Nemati,et al.  Effects of conjugated linoleic acid supplementation on serum levels of interleukin-6 and sirtuin 1 in COPD patients , 2020, Avicenna journal of phytomedicine.

[9]  V. Fuster,et al.  The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. , 2019, Journal of the American College of Cardiology.

[10]  A. Rahbar,et al.  Effects of Conjugated Linoleic Acid Intake in the Form of Dietary Supplement or Enriched Food on C-Reactive Protein and Lipoprotein (a) Levels in Humans: A Literature Review and Meta-Analysis , 2019, Iranian journal of medical sciences.

[11]  S. Ghavamzadeh,et al.  The Effect of Conjugated Linoleic Acid Supplementation on Body Composition, Serum Insulin and Leptin in Obese Adults. , 2019, Archives of Iranian medicine.

[12]  G. Randolph,et al.  Cytokine Circuits in Cardiovascular Disease. , 2019, Immunity.

[13]  F. Haghighatdoost,et al.  Effect of conjugated linoleic acid on blood inflammatory markers: a systematic review and meta-analysis on randomized controlled trials , 2018, European Journal of Clinical Nutrition.

[14]  Nam Hoon Kim,et al.  Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study , 2018, Scientific Reports.

[15]  F. Haghighatdoost,et al.  Effect of Conjugated Linoleic Acid Supplementation on Serum Leptin Concentration: A Systematic Review and Meta-Analysis. , 2017, Endocrine, metabolic & immune disorders drug targets.

[16]  M. Mazidi,et al.  Effects of conjugated linoleic acid supplementation on serum C‐reactive protein: A systematic review and meta‐analysis of randomized controlled trials , 2017, Cardiovascular therapeutics.

[17]  J. Tune,et al.  Cardiovascular consequences of metabolic syndrome. , 2017, Translational research : the journal of laboratory and clinical medicine.

[18]  L. Janani,et al.  Effect of Conjugated Linoleic Acid as a Supplement or Enrichment in Foods on Blood Glucose and Waist Circumference in Humans: A Metaanalysis. , 2017, Endocrine, metabolic & immune disorders drug targets.

[19]  J. Bassaganya-Riera,et al.  Modulation of inflammation and immunity by dietary conjugated linoleic acid. , 2016, European journal of pharmacology.

[20]  M. Ebrahimi-Mameghani,et al.  Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial , 2016, Croatian medical journal.

[21]  R. Kelishadi,et al.  Association of conjugated linoleic acid consumption and liver enzymes in human studies: A systematic review and meta-analysis of randomized controlled clinical trials. , 2016, Nutrition.

[22]  A. Marcadenti,et al.  A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism , 2015, Journal of the International Society of Sports Nutrition.

[23]  C. M. Sabarense,et al.  Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats. , 2015, Journal of oleo science.

[24]  Kazuto Nakamura,et al.  Adipokines: a link between obesity and cardiovascular disease. , 2014, Journal of cardiology.

[25]  F. Aliasghari,et al.  Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients , 2013, ARYA atherosclerosis.

[26]  M. Hedayati,et al.  Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics , 2013, Journal of Diabetes & Metabolic Disorders.

[27]  P. Pozzilli,et al.  Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes? , 2013, Diabetes Care.

[28]  Roberta F Carvalho,et al.  Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome , 2012, Vascular health and risk management.

[29]  V. DeClercq,et al.  Conjugated linoleic acid improves blood pressure by increasing adiponectin and endothelial nitric oxide synthase activity. , 2012, The Journal of nutritional biochemistry.

[30]  J. Schrezenmeir,et al.  Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism , 2012, Genes & Nutrition.

[31]  M. Fromm,et al.  Activated AMPK and prostaglandins are involved in the response to conjugated linoleic acid and are sufficient to cause lipid reductions in adipocytes. , 2011, The Journal of nutritional biochemistry.

[32]  R. McLeod,et al.  Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. , 2011, The Journal of nutrition.

[33]  V. DeClercq,et al.  Modulation of lipid droplet size and lipid droplet proteins by trans-10,cis-12 conjugated linoleic acid parallels improvements in hepatic steatosis in obese, insulin-resistant rats. , 2010, Biochimica et biophysica acta.

[34]  P. Illesca,et al.  Conjugated Linoleic Acid Reduces Hepatic Steatosis and Restores Liver Triacylglycerol Secretion and the Fatty Acid Profile During Protein Repletion in Rats , 2010, Lipids.

[35]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[36]  P. Delmonte,et al.  Dietary trans fatty acid isomers differ in their effects on mammary lipid metabolism as well as lipogenic gene expression in lactating mice. , 2010, The Journal of nutrition.

[37]  J. Hsu,et al.  Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. , 2009, The American journal of clinical nutrition.

[38]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[39]  Wen-sheng Zhao,et al.  Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension. , 2009, American journal of hypertension.

[40]  P. Zahradka,et al.  Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats. , 2007, Metabolism: clinical and experimental.

[41]  E. Kang,et al.  Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes. , 2006, European journal of endocrinology.

[42]  J. Chardigny,et al.  Cis-9, trans- 11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B. , 2006, Atherosclerosis.

[43]  H. Roche,et al.  Divergent mechanisms of cis9, trans11‐ and trans10, cis12‐conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  I. Hozo,et al.  Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.

[45]  P. Calder,et al.  Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans. , 2004, The American journal of clinical nutrition.

[46]  H. Roche,et al.  Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. , 2004, The American journal of clinical nutrition.

[47]  P. Calder,et al.  Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. , 2004, The American journal of clinical nutrition.

[48]  J. Árnlöv,et al.  Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. , 2004, The American journal of clinical nutrition.

[49]  P. J. Jones,et al.  Conjugated linoleic acid and obesity control: efficacy and mechanisms , 2004, International Journal of Obesity.

[50]  L. Spriet,et al.  Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. , 2004, Medicine and science in sports and exercise.

[51]  S. Toubro,et al.  Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. , 2003, Journal of lipid research.

[52]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[53]  Yuh-Feng Lin,et al.  Correlation of Serum Leptin Concentrations with Body Composition and Gender in Taiwanese Hemodialysis Patients without Diabetes , 2003, Renal failure.

[54]  P. Arner,et al.  Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. , 2002, Diabetes care.

[55]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[56]  M. Khan,et al.  Increased malondialdehyde levels in coronary heart disease. , 2000, JPMA. The Journal of the Pakistan Medical Association.

[57]  E. Medina,et al.  Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentrations and appetite , 2000, Lipids.

[58]  J. DeLany,et al.  Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[59]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[60]  Mahesh S. Patel.  An introduction to meta-analysis. , 1989, Health policy.

[61]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[62]  R. Duggirala,et al.  Effects of Conjugated Linoleic Acid and Metformin on Insulin Sensitivity in Obese Children: Randomized Clinical Trial , 2017, The Journal of clinical endocrinology and metabolism.

[63]  Y. Mehrabi,et al.  Effects of Conjugated Linoleic Acid on Insulin Sensitivity and Diabetes Markers in Type 2 Diabetic Patients , 2009 .

[64]  B. Schmitt,et al.  Effet d’un régime riche en acides gras ω3 et en CLA 9-cis, 11-trans sur l’insulinorésistance et les paramètres du diabète de type 2 , 2006 .

[65]  J. M. Block,et al.  [Conjugated linoleic acid (CLA) and its relationship with cardiovascular disease and associated risk factors]. , 2006, Archivos latinoamericanos de nutricion.

[66]  Feng Li,et al.  An Introduction to Metaanalysis , 2005 .

[67]  M. Belury,et al.  The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. , 2003, The Journal of nutrition.

[68]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[69]  A. Tobías.  Assessing the influence of a single study in the meta-anyalysis estimate , 1999 .

[70]  Bias in meta›analysis detected by a simple, graphical test , 1998 .